In the case of ‘Patanjali Ayurveda Limited’ circulating alleged misleading advertisements about its products, ‘IMA’ had filed a petition in the Supreme Court.
Taking note of the interview, the Supreme Court had stated, “We expected more sense of responsibility from you.
People have faith in Baba Ramdev. People look up to him. The only concern was that the public should be well informed.
No surprise if someone feels that the Supreme Court should also ask for a public apology from the IMA president as well.
About this apology, Patanjali’s advocate Mukul Rohatgi told the court that the advertisement cost Rs 10 lakh and was published in 67 newspapers.
The Supreme Court refuted this petition and upheld the decision of the Appellate Tribunal.
The Bench of Justice Ahsanuddin Amanullah and Justice Hima Kohli expressed displeasure over the Uttarakhand State Licensing Authority (USLA) for its inaction.
The Court issued the above warning while hearing a petition filed by the Indian Medical Association (Indian Medical Association) against Patanjali’s advertisements.
Acharya Balkrushna, Director of Patanjali informed about it. The government had banned BPgrit, Madhugrit, Thyrogrit, Lipidome and Eyegrit medicines.
BJP Government in Uttarakhand has banned five drugs of Yogarushi Ramdevbaba’s Patanjali Group of Companies. These drugs are manufactured in Patanjali’s ‘Divya Pharmacy’.